Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2000-07-14
2002-01-01
Hartley, Michael G. (Department: 1619)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C424S401000, C548S454000
Reexamination Certificate
active
06335359
ABSTRACT:
CROSS-REFERENCE TO PRIORITY APPLICATION
This application claims priority under 35 U.S.C. §119 of FR-99/09269, filed Jul. 16, 1999, hereby expressly incorporated by reference.
BACKGROUND OF THE INVENTION
1. Technical Field of the Invention
The present invention relates to novel cosmetic/dermatological compositions containing a therapeutically effective amount of 4,6-dimethoxyindole-2-carboxylic acid or derivatives thereof, for treating seborrhoea and the dermatitides associated therewith, in particular acne and/or blackheads and/or comedones.
2. Description of the Prior Art
Seborrhoea or sebaceous hypersecretion is the cause of skin disorders such as greasy skin and a greasy scalp, these aesthetic disorders potentially becoming a source for dermatological afflictions/conditions such as acne, seborrhoeic dermatitis, blackheads or comedones.
Acne is one of the conditions usually affecting, and to varying degrees, the juvenile population between 15 and 30 years old. Acne is essentially the consequence of two interlinked phenomena: sebaceous hypersecretion and disruption of the keratinization of the pilosebaceous follicles, the consequences of which are obstruction of the pilosebaceous follicles and the formation of retentive lesions or comedones. Following microbial proliferation, the comedones can develop into inflammatory lesions, papules and pustules.
Seborrhoeic dermatitis is associated with the proliferation of yeasts of the Pityrosporum genus on the sebum which constitutes their substrate.
In the case of both acne and seborrhoeic dermatitis, regulating the sebaceous flux eliminates the initial cause, i.e., the excessive presence of sebum, and consequently treats the dermatitis.
This is what is observed with isotretinoin, the oral administration of which induces drying-out of the sebaceous follicles and leads to disappearance of the symptoms.
However, the administration of isotretinoin is not without serious side effects and consequently remains reserved for the treatment of severe, incapacitating acne. Topical treatments of seborrhoea have hitherto proven to be relatively ineffective, and this lack of efficacy is frequently overcome by means of systemic treatments, in particular with isotretinoin or anti-androgenic products.
Thus, serious need continues to exist for topical active agents which favorably influence sebaceous hypersecretion and consequently the dermatitides associated therewith.
SUMMARY OF THE INVENTION
It has now surprisingly and unexpectedly been determined that 4,6-dimethoxyindole-2-carboxylic acid and derivatives thereof exhibit antiseborrhoeic properties and are thus useful active agents for combating seborrhoea of the skin or the scalp, and for combating the dermatitides which may result therefrom, such as acne, seborrhoeic dermatitis, blackheads and/or comedones.
Briefly, the present invention features cosmetic/dermatological compositions comprising a therapeutically effective antiseborrhoeic amount of at least one compound having the structural formula (I):
in which R
1
and R
2
, which may be identical or different, are each a hydrogen atom; a C
1
-C
6
alkyl radical, optionally substituted with an —OH, —NHR
3
, —SH, —COOH or —COOR
3
radical, wherein R
3
is a linear or branched C
1
-C
4
alkyl radical; a C
7
-C
12
aralkyl radical; or a radical —CHR
4
R
5
wherein R
4
and R
5
, which may be identical or different, are each a hydrogen atom, an optionally substituted phenyl radical, or a 5- or 6-membered heterocycle; the acylated derivatives or the physiologically acceptable salts thereof, either singly or in any admixture; for treating seborrhoea of the skin and/or the scalp, and/or the dermatitides associated with seborrhoea.
DETAILED DESCRIPTION OF BEST MODE AND SPECIFIC/PREFERRED EMBODIMENTS OF THE INVENTION
More particularly according to the present invention, the dermatitis associated with seborrhoea can be, especially acne, and/or blackheads and/or comedones.
The subject compounds exhibit marked utility as active principles for preventively and/or curatively treating seborrhoea of the skin and/or the scalp, as well as the dermatitides associated with seborrhoea, such as acne and/or blackheads and/or comedones.
It was hitherto unknown to use such compounds to treat seborrhoea of the skin and/or the scalp, and the dermatitides associated with seborrhoea, such as acne and/or blackheads and/or comedones has never been proposed in the prior art.
According to this invention, by the term “heterocycle” is preferably intended a ring optionally including one or more nitrogen and/or oxygen atoms and more particularly pyridine, imidazole, tetrahydrofuran or furan. One heterocycle which is particularly preferred according to the invention is pyridine.
By the expression “C
1
-C
4
alkyl radical” are intended linear or branched acyclic radicals having from 1 to 4 carbon atoms, derived from the removal of a hydrogen atom from a hydrocarbon molecule, and in particular methyl, ethyl, propyl, isopropyl, butyl, isobutyl or tert-butyl radicals.
By the expression “C
7
-C
12
aralkyl radical” are preferably intended alkylaryl radicals having from 7 to 12 carbon atoms, in which definition the term “aryl” connotes an aromatic ring containing 5 or 6 carbon atoms or an aromatic heterocycle containing 5 or 6 atoms. According to the invention, the aralkyl radical is preferably C
7
-C
10
. One aralkyl radical which is particularly preferred according to the invention is the benzyl radical.
And by the expression “optionally substituted phenyl radical” is preferably intended a phenyl radical optionally substituted with a cyano (—CN) group, a trifluoromethyl (—CF
3
) group, a methoxy (—O—CH
3
) group or a halogen atom. The halogen atom can be selected from among chlorine, bromine, fluorine and iodine. One substituted phenyl radical which is particularly preferred according to the invention is a phenyl radical substituted with a trifluoromethyl (—CF
3
) group.
In one preferred embodiment of the invention, R
1
is a hydrogen atom or a methyl or ethyl radical.
In another preferred embodiment of the invention, R
2
is a hydrogen atom or a methyl radical.
And in a very preferred embodiment of the invention, R
1
and R
2
are each a hydrogen atom.
Exemplary compounds of formula (I) include:
4,6-dimethoxyindole-2-carboxylic acid;
methyl 4,6-dimethoxyindole-2-carboxylate;
N-methyl-4,6-dimethoxyindole-2-carboxylic acid;
methyl N-methyl-4,6-dimethoxyindole-2-carboxylate;
N-ethyl-4,6-dimethoxyindole-2-carboxylic acid.
Among these compounds, that most particularly preferred is 4,6-dimethoxyindole-2-carboxylic acid.
According to the invention, the subject compounds can be used alone or as a mixture.
It will of course be appreciated that the effective amount of compound to be administered corresponds to the amount required to elicit the desired result. One skilled in this art is thus capable of evaluating this effective amount, which depends on the nature of the compound and on the individual thus treated. To provide an order of magnitude, in the compositions according to the invention the compound of formula (I) is typically present in a concentration ranging from 0.001% to 20% by weight relative to the total weight of the composition and preferably from 0.1% to 5%.
According to the present invention, the compounds of formula (I) can be formulated into any suitable medium (vehicle, diluent or carrier) for cosmetic and pharmaceutical applications. The compounds of formula (I) are preferentially formulated into compositions for cosmetic application.
The compositions according to the invention can be in any form which is suitable for topical application, in particular in the form of aqueous, aqueous/alcoholic or oily solutions, dispersions of the lotion or serum type, aqueous, anhydrous or oily gels, ointments, emulsions of liquid or semi-liquid consistency of the milk type, obtained by dispersing a fatty phase in an aqueous phase (O/W) or, conversely, (W/O), suspensions or emulsions of soft, semi-solid or solid consistency of the cream or gel type, microemulsions, or alternatively microcap
Bernard Bruno
Dalko Maria
Galey Jean-Baptiste
Burns Doane Swecker & Mathis L.L.P.
Hartley Michael G.
Societe L'Oreal S.A.
Willis Michael D.
LandOfFree
Indolecarboxylic compounds for treating seborrhea and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolecarboxylic compounds for treating seborrhea and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolecarboxylic compounds for treating seborrhea and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2821098